Search

Your search keyword '"Immunologic Tests economics"' showing total 55 results

Search Constraints

Start Over You searched for: Descriptor "Immunologic Tests economics" Remove constraint Descriptor: "Immunologic Tests economics"
55 results on '"Immunologic Tests economics"'

Search Results

1. Testing and Treating Helicobacter pylori Infection in Individuals With Family History of Gastric Cancer is Cost-effective.

2. Hepatitis C virus antigen detection is an appropriate test for screening and early diagnosis of hepatitis C virus infection in at-risk populations and immunocompromised hosts.

3. Well-Based Antibody Arrays.

4. Allergy Testing - An Overview.

5. Impact of Adopting Routine Luminex-Based Pretransplant Assessment of HLA Antibodies on Clinical Practice and Outcomes in Kidney Transplantation.

6. HCV core antigen comes of age: a new opportunity for the diagnosis of hepatitis C virus infection.

7. Sensitivity, specificity and comparison of three commercially available immunological tests in the diagnosis of Cryptosporidium species in animals.

8. Greater Real-Life Diagnostic Efficacy of Allergen Molecule-Based Diagnosis for Prescription of Immunotherapy in an Area with Multiple Pollen Exposure.

9. [Rising demand for immunodiagnosis].

10. Determining safe alternatives for multidrug hypersensitive patients with the alternative triple antibiotic-analgesic test.

11. New developments in the immunodiagnosis of brucellosis in livestock and wildlife.

12. Identification and discrimination of snake venoms from Egyptian elapids.

13. Developing a framework for risk-based surveillance of tuberculosis in cattle: a case study of its application in Scotland.

14. Are anti-nucleosome antibodies a better diagnostic marker than anti-dsDNA antibodies for systemic lupus erythematosus? A systematic review and a study of metanalysis.

15. Rescreening of persons with a negative colonoscopy result: results from a microsimulation model.

16. Screening for colorectal cancer: what fits best?

17. [Immunodiagnosis and biomarkers in tuberculosis].

18. Tetanus Quick Stick as an applicable and cost-effective test in assessment of immunity status.

19. Cost-effectiveness of mass screening for colorectal cancer: choice of fecal occult blood test and screening strategy.

20. Cost-effectiveness analysis of interferon-γ release assays versus chest X-ray for annual tuberculosis screening of healthcare workers.

21. Utilization of the QuantiFERON-TB Gold test in a two-step process with the tuberculin skin test to evaluate health care workers for latent tuberculosis.

22. Cost effectiveness of interferon-gamma release assay versus chest X-ray for tuberculosis screening of BCG-vaccinated elderly populations.

23. Rational use of immunodiagnostic tools for tuberculosis infection: guidelines and cost effectiveness studies.

24. Population screening for coeliac disease in primary care by district nurses using a rapid antibody test: diagnostic accuracy and feasibility study.

26. Application of a combined protocol for rational request and utilization of antibody assays improves clinical diagnostic efficacy in autoimmune rheumatic disease.

27. Ensuring quality and access for malaria diagnosis: how can it be achieved?

28. The routine use of high-resolution immunological screening of recipients of primary deceased donor kidney allografts is cost-effective.

29. Comparison of a monoclonal antigen stool test (Hp StAR) with the 13C-urea breath test in monitoring Helicobacter pylori eradication therapy.

30. [What can be tested in a blood sample. Immunologic laboratory mice].

31. The role of the clinical immunology laboratory in the diagnosis and monitoring of connective tissue diseases.

32. A cost analysis of the use of the rapid, whole-blood, immunochromatographic P.f/P.v assay for the diagnosis of Plasmodium vivax malaria in a rural area of Sri Lanka.

34. [The use of rapid tests for individual diagnosis of influenza].

35. Value of in vitro allergy testing.

36. Diagnosis of lupus: a glass half full.

37. A comparison study of different methods used in the detection of Giardia lamblia.

38. Prevalence of hepatitis A virus and hepatitis B virus immunity in patients with polymerase chain reaction-confirmed hepatitis C: implications for vaccination strategy.

39. Workload generated by a living donor programme for renal transplantation.

40. [Increasing use of laboratory tests--a controllable process?].

41. A comparison of three malaria diagnostic tests, under field conditions in North-west Thailand.

42. A new method with general diagnostic utility for the calculation of immunoglobulin G avidity.

43. Autoantibody screening for infertility: explaining the unexplained?

44. [Cost-effective approach to the screening of HIV, HBV, HCV, HTLV in blood donors in France].

45. The prevalence and direct costs of pre-immunization testing for hepatitis A in general practice.

46. Management of the presumed susceptible varicella (chickenpox)-exposed gravida: a cost-effectiveness/cost-benefit analysis.

49. Cost-effectiveness of various methods of diagnosing hypersensitivity to Alternaria.

50. [Cost-benefit relationship of serologic studies in autoimmune diseases].

Catalog

Books, media, physical & digital resources